Medical Care
Global Infectious Diseases In Vitro Diagnostics Market Research Report 2025
- Jul 08, 25
- ID: 347365
- Pages: 85
- Figures: 83
- Views: 46
The global market for Infectious Diseases In Vitro Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Diseases In Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases In Vitro Diagnostics.
The Infectious Diseases In Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Diseases In Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Diseases In Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Abbott
Alere
Quidel
F. Hoffmann-La Roche
Orasure Technologies
Cepheid
Hologic
Qiagen
Bio-Rad Laboratories
Siemens Healthcare
Segment by Type
MRSA
Streptococcus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis C
Others
Segment by Application
Immunochemistry
Molecular Diagnostics
Microbiology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases In Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Diseases In Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases In Vitro Diagnostics.
The Infectious Diseases In Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Diseases In Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Diseases In Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Abbott
Alere
Quidel
F. Hoffmann-La Roche
Orasure Technologies
Cepheid
Hologic
Qiagen
Bio-Rad Laboratories
Siemens Healthcare
Segment by Type
MRSA
Streptococcus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis C
Others
Segment by Application
Immunochemistry
Molecular Diagnostics
Microbiology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases In Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 MRSA
1.2.3 Streptococcus
1.2.4 TB and Drug-resistant TB
1.2.5 Gastro-intestinal Panel Testing
1.2.6 HIV
1.2.7 Hepatitis C
1.2.8 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases In Vitro Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry
1.3.3 Molecular Diagnostics
1.3.4 Microbiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Diseases In Vitro Diagnostics Market Perspective (2020-2031)
2.2 Global Infectious Diseases In Vitro Diagnostics Growth Trends by Region
2.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Diseases In Vitro Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Infectious Diseases In Vitro Diagnostics Market Dynamics
2.3.1 Infectious Diseases In Vitro Diagnostics Industry Trends
2.3.2 Infectious Diseases In Vitro Diagnostics Market Drivers
2.3.3 Infectious Diseases In Vitro Diagnostics Market Challenges
2.3.4 Infectious Diseases In Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue
3.1.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Diseases In Vitro Diagnostics Revenue
3.4 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases In Vitro Diagnostics Revenue in 2024
3.5 Global Key Players of Infectious Diseases In Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
3.7 Global Key Players of Infectious Diseases In Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Diseases In Vitro Diagnostics Breakdown Data by Type
4.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2026-2031)
5 Infectious Diseases In Vitro Diagnostics Breakdown Data by Application
5.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
6.2 North America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025)
6.4 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
7.2 Europe Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025)
7.4 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
9.2 Latin America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Infectious Diseases In Vitro Diagnostics Introduction
11.1.4 BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.1.5 BD Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Diseases In Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Alere
11.3.1 Alere Company Details
11.3.2 Alere Business Overview
11.3.3 Alere Infectious Diseases In Vitro Diagnostics Introduction
11.3.4 Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.3.5 Alere Recent Development
11.4 Quidel
11.4.1 Quidel Company Details
11.4.2 Quidel Business Overview
11.4.3 Quidel Infectious Diseases In Vitro Diagnostics Introduction
11.4.4 Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.4.5 Quidel Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Orasure Technologies
11.6.1 Orasure Technologies Company Details
11.6.2 Orasure Technologies Business Overview
11.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Introduction
11.6.4 Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.6.5 Orasure Technologies Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Introduction
11.7.4 Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.7.5 Cepheid Recent Development
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic Infectious Diseases In Vitro Diagnostics Introduction
11.8.4 Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.8.5 Hologic Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Introduction
11.9.4 Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.9.5 Qiagen Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Introduction
11.11.4 Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.11.5 Siemens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 MRSA
1.2.3 Streptococcus
1.2.4 TB and Drug-resistant TB
1.2.5 Gastro-intestinal Panel Testing
1.2.6 HIV
1.2.7 Hepatitis C
1.2.8 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases In Vitro Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry
1.3.3 Molecular Diagnostics
1.3.4 Microbiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Diseases In Vitro Diagnostics Market Perspective (2020-2031)
2.2 Global Infectious Diseases In Vitro Diagnostics Growth Trends by Region
2.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Diseases In Vitro Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Infectious Diseases In Vitro Diagnostics Market Dynamics
2.3.1 Infectious Diseases In Vitro Diagnostics Industry Trends
2.3.2 Infectious Diseases In Vitro Diagnostics Market Drivers
2.3.3 Infectious Diseases In Vitro Diagnostics Market Challenges
2.3.4 Infectious Diseases In Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue
3.1.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Diseases In Vitro Diagnostics Revenue
3.4 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases In Vitro Diagnostics Revenue in 2024
3.5 Global Key Players of Infectious Diseases In Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
3.7 Global Key Players of Infectious Diseases In Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Diseases In Vitro Diagnostics Breakdown Data by Type
4.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2026-2031)
5 Infectious Diseases In Vitro Diagnostics Breakdown Data by Application
5.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
6.2 North America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025)
6.4 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
7.2 Europe Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025)
7.4 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
9.2 Latin America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Infectious Diseases In Vitro Diagnostics Introduction
11.1.4 BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.1.5 BD Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Diseases In Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Alere
11.3.1 Alere Company Details
11.3.2 Alere Business Overview
11.3.3 Alere Infectious Diseases In Vitro Diagnostics Introduction
11.3.4 Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.3.5 Alere Recent Development
11.4 Quidel
11.4.1 Quidel Company Details
11.4.2 Quidel Business Overview
11.4.3 Quidel Infectious Diseases In Vitro Diagnostics Introduction
11.4.4 Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.4.5 Quidel Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Orasure Technologies
11.6.1 Orasure Technologies Company Details
11.6.2 Orasure Technologies Business Overview
11.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Introduction
11.6.4 Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.6.5 Orasure Technologies Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Introduction
11.7.4 Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.7.5 Cepheid Recent Development
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic Infectious Diseases In Vitro Diagnostics Introduction
11.8.4 Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.8.5 Hologic Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Introduction
11.9.4 Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.9.5 Qiagen Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Introduction
11.11.4 Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
11.11.5 Siemens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of MRSA
Table 3. Key Players of Streptococcus
Table 4. Key Players of TB and Drug-resistant TB
Table 5. Key Players of Gastro-intestinal Panel Testing
Table 6. Key Players of HIV
Table 7. Key Players of Hepatitis C
Table 8. Key Players of Others
Table 9. Global Infectious Diseases In Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2020-2025)
Table 13. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2026-2031)
Table 15. Infectious Diseases In Vitro Diagnostics Market Trends
Table 16. Infectious Diseases In Vitro Diagnostics Market Drivers
Table 17. Infectious Diseases In Vitro Diagnostics Market Challenges
Table 18. Infectious Diseases In Vitro Diagnostics Market Restraints
Table 19. Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players (2020-2025)
Table 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2024)
Table 22. Ranking of Global Top Infectious Diseases In Vitro Diagnostics Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Infectious Diseases In Vitro Diagnostics, Headquarters and Area Served
Table 25. Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
Table 26. Global Key Players of Infectious Diseases In Vitro Diagnostics, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Diseases In Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Table 30. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2026-2031)
Table 32. Global Infectious Diseases In Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Table 34. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2026-2031)
Table 36. North America Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 51. BD Company Details
Table 52. BD Business Overview
Table 53. BD Infectious Diseases In Vitro Diagnostics Product
Table 54. BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 55. BD Recent Development
Table 56. Abbott Company Details
Table 57. Abbott Business Overview
Table 58. Abbott Infectious Diseases In Vitro Diagnostics Product
Table 59. Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Alere Company Details
Table 62. Alere Business Overview
Table 63. Alere Infectious Diseases In Vitro Diagnostics Product
Table 64. Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Alere Recent Development
Table 66. Quidel Company Details
Table 67. Quidel Business Overview
Table 68. Quidel Infectious Diseases In Vitro Diagnostics Product
Table 69. Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Quidel Recent Development
Table 71. F. Hoffmann-La Roche Company Details
Table 72. F. Hoffmann-La Roche Business Overview
Table 73. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product
Table 74. F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Orasure Technologies Company Details
Table 77. Orasure Technologies Business Overview
Table 78. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product
Table 79. Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Orasure Technologies Recent Development
Table 81. Cepheid Company Details
Table 82. Cepheid Business Overview
Table 83. Cepheid Infectious Diseases In Vitro Diagnostics Product
Table 84. Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Cepheid Recent Development
Table 86. Hologic Company Details
Table 87. Hologic Business Overview
Table 88. Hologic Infectious Diseases In Vitro Diagnostics Product
Table 89. Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Hologic Recent Development
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Infectious Diseases In Vitro Diagnostics Product
Table 94. Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Qiagen Recent Development
Table 96. Bio-Rad Laboratories Company Details
Table 97. Bio-Rad Laboratories Business Overview
Table 98. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product
Table 99. Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Bio-Rad Laboratories Recent Development
Table 101. Siemens Healthcare Company Details
Table 102. Siemens Healthcare Business Overview
Table 103. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product
Table 104. Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 105. Siemens Healthcare Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Infectious Diseases In Vitro Diagnostics Picture
Figure 2. Global Infectious Diseases In Vitro Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Infectious Diseases In Vitro Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. MRSA Features
Figure 5. Streptococcus Features
Figure 6. TB and Drug-resistant TB Features
Figure 7. Gastro-intestinal Panel Testing Features
Figure 8. HIV Features
Figure 9. Hepatitis C Features
Figure 10. Others Features
Figure 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Application: 2024 VS 2031
Figure 13. Immunochemistry Case Studies
Figure 14. Molecular Diagnostics Case Studies
Figure 15. Microbiology Case Studies
Figure 16. Others Case Studies
Figure 17. Infectious Diseases In Vitro Diagnostics Report Years Considered
Figure 18. Global Infectious Diseases In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Infectious Diseases In Vitro Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Region: 2024 VS 2031
Figure 21. Global Infectious Diseases In Vitro Diagnostics Market Share by Players in 2024
Figure 22. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue in 2024
Figure 24. North America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Infectious Diseases In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 26. United States Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Infectious Diseases In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 30. Germany Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Share by Region (2020-2031)
Figure 38. China Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Infectious Diseases In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 46. Mexico Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 50. Turkey Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. BD Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 54. Abbott Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 55. Alere Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 56. Quidel Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 58. Orasure Technologies Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 59. Cepheid Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 60. Hologic Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 61. Qiagen Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 63. Siemens Healthcare Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of MRSA
Table 3. Key Players of Streptococcus
Table 4. Key Players of TB and Drug-resistant TB
Table 5. Key Players of Gastro-intestinal Panel Testing
Table 6. Key Players of HIV
Table 7. Key Players of Hepatitis C
Table 8. Key Players of Others
Table 9. Global Infectious Diseases In Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2020-2025)
Table 13. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2026-2031)
Table 15. Infectious Diseases In Vitro Diagnostics Market Trends
Table 16. Infectious Diseases In Vitro Diagnostics Market Drivers
Table 17. Infectious Diseases In Vitro Diagnostics Market Challenges
Table 18. Infectious Diseases In Vitro Diagnostics Market Restraints
Table 19. Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players (2020-2025)
Table 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2024)
Table 22. Ranking of Global Top Infectious Diseases In Vitro Diagnostics Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Infectious Diseases In Vitro Diagnostics, Headquarters and Area Served
Table 25. Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
Table 26. Global Key Players of Infectious Diseases In Vitro Diagnostics, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Diseases In Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Table 30. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2026-2031)
Table 32. Global Infectious Diseases In Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Table 34. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2026-2031)
Table 36. North America Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 51. BD Company Details
Table 52. BD Business Overview
Table 53. BD Infectious Diseases In Vitro Diagnostics Product
Table 54. BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 55. BD Recent Development
Table 56. Abbott Company Details
Table 57. Abbott Business Overview
Table 58. Abbott Infectious Diseases In Vitro Diagnostics Product
Table 59. Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Alere Company Details
Table 62. Alere Business Overview
Table 63. Alere Infectious Diseases In Vitro Diagnostics Product
Table 64. Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Alere Recent Development
Table 66. Quidel Company Details
Table 67. Quidel Business Overview
Table 68. Quidel Infectious Diseases In Vitro Diagnostics Product
Table 69. Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Quidel Recent Development
Table 71. F. Hoffmann-La Roche Company Details
Table 72. F. Hoffmann-La Roche Business Overview
Table 73. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product
Table 74. F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Orasure Technologies Company Details
Table 77. Orasure Technologies Business Overview
Table 78. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product
Table 79. Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Orasure Technologies Recent Development
Table 81. Cepheid Company Details
Table 82. Cepheid Business Overview
Table 83. Cepheid Infectious Diseases In Vitro Diagnostics Product
Table 84. Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Cepheid Recent Development
Table 86. Hologic Company Details
Table 87. Hologic Business Overview
Table 88. Hologic Infectious Diseases In Vitro Diagnostics Product
Table 89. Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Hologic Recent Development
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Infectious Diseases In Vitro Diagnostics Product
Table 94. Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Qiagen Recent Development
Table 96. Bio-Rad Laboratories Company Details
Table 97. Bio-Rad Laboratories Business Overview
Table 98. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product
Table 99. Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Bio-Rad Laboratories Recent Development
Table 101. Siemens Healthcare Company Details
Table 102. Siemens Healthcare Business Overview
Table 103. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product
Table 104. Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 105. Siemens Healthcare Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Infectious Diseases In Vitro Diagnostics Picture
Figure 2. Global Infectious Diseases In Vitro Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Infectious Diseases In Vitro Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. MRSA Features
Figure 5. Streptococcus Features
Figure 6. TB and Drug-resistant TB Features
Figure 7. Gastro-intestinal Panel Testing Features
Figure 8. HIV Features
Figure 9. Hepatitis C Features
Figure 10. Others Features
Figure 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Application: 2024 VS 2031
Figure 13. Immunochemistry Case Studies
Figure 14. Molecular Diagnostics Case Studies
Figure 15. Microbiology Case Studies
Figure 16. Others Case Studies
Figure 17. Infectious Diseases In Vitro Diagnostics Report Years Considered
Figure 18. Global Infectious Diseases In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Infectious Diseases In Vitro Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Region: 2024 VS 2031
Figure 21. Global Infectious Diseases In Vitro Diagnostics Market Share by Players in 2024
Figure 22. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue in 2024
Figure 24. North America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Infectious Diseases In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 26. United States Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Infectious Diseases In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 30. Germany Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Share by Region (2020-2031)
Figure 38. China Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Infectious Diseases In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 46. Mexico Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 50. Turkey Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. BD Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 54. Abbott Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 55. Alere Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 56. Quidel Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 58. Orasure Technologies Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 59. Cepheid Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 60. Hologic Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 61. Qiagen Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 63. Siemens Healthcare Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232